News
DNPUF
4.000
NaN%
--
Weekly Report: what happened at DNPUF last week (0407-0411)?
Weekly Report · 04/14 11:03
Weekly Report: what happened at DNPUF last week (0331-0404)?
Weekly Report · 04/07 11:02
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 04/06 12:15
Sumitomo Pharma Extends Executive Pay Cuts Amid Financial Challenges
TipRanks · 04/04 06:55
Sumitomo Pharma Transfers Asian Business to Marubeni Subsidiary
TipRanks · 04/01 07:02
Weekly Report: what happened at DNPUF last week (0324-0328)?
Weekly Report · 03/31 11:13
Sumitomo Pharma to Enhance Governance with New Audit Committee Structure
TipRanks · 03/28 07:24
Sumitomo Pharma Refinances Borrowings to Stabilize Finances
TipRanks · 03/26 02:52
Weekly Report: what happened at DNPUF last week (0317-0321)?
Weekly Report · 03/24 11:02
Weekly Report: what happened at DNPUF last week (0310-0314)?
Weekly Report · 03/17 11:12
Weekly Report: what happened at DNPUF last week (0303-0307)?
Weekly Report · 03/10 11:14
Weekly Report: what happened at DNPUF last week (0224-0228)?
Weekly Report · 03/03 11:13
Sumitomo Pharma Announces Strategic Capital Reorganization
TipRanks · 02/28 07:02
Weekly Report: what happened at DNPUF last week (0217-0221)?
Weekly Report · 02/24 11:12
Weekly Report: what happened at DNPUF last week (0210-0214)?
Weekly Report · 02/17 11:10
Weekly Report: what happened at DNPUF last week (0203-0207)?
Weekly Report · 02/10 11:05
Weekly Report: what happened at DNPUF last week (0127-0131)?
Weekly Report · 02/03 11:09
Sumitomo Dainippon Pharma Reports Robust Earnings Growth
TipRanks · 02/01 03:59
Sumitomo Pharma Revises Financial Forecasts, Projects Positive Turnaround
TipRanks · 01/31 07:06
Sumitomo Pharma Reports Significant Foreign Exchange Gains
TipRanks · 01/31 07:05
More
Webull provides a variety of real-time DNPUF stock news. You can receive the latest news about DAI Nippon Pharm through multiple platforms. This information may help you make smarter investment decisions.
About DNPUF
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.